Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2026 Earnings Call Transcript May 5, 2026
Arcus Biosciences, Inc. misses on earnings expectations. Reported EPS is $-1.02 EPS, expectations were $-0.92.
Operator: Hello, everyone. Thank you for joining us, and welcome to the Arcus Biosciences, Inc. First Quarter 2026 Business Update and Financial Results. After today’s prepared remarks, we will host a question and answer session. Please limit yourself to one question and one follow-up. If you would like...
